Yanming Xing

694 citations
9 papers · 287 indexed · h-index 7
Topics
Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers)Alzheimer's disease research and treatments (7 papers)Prion Diseases and Protein Misfolding (6 papers)
Partner nations
JapanUnited States

In The Last Decade

Yanming Xing

9 papers receiving 279 citations

Peers

Yanming Xing
Comparison fields: 5 of 61
  • Molecular Biology 249
  • Physiology 135
  • Nutrition and Dietetics 57
  • Neurology 32
  • Genetics 28
Replace Ricardo Sant’Anna with:
Ricardo Sant’Anna Brazil
Gian Franco Sferrazza United States
Sarah L. Cocklin United States
Tatsuki Yokoseki Japan
Cristina Batlle Spain
Gaëtan Herinckx Belgium
Yongyao Wang China
Shigenari Hayashi United States
Vivek P. Patel United States
S R Tyagi United States
Yanming Xing relative to Ricardo Sant’Anna Brazil Ricardo Sant’Anna's profile →
Citations per field
00.5×2.5×
Ricardo Sant’Anna · 1×
Citations per year

Countries citing papers authored by Yanming Xing

Since Specialization
Citations

This map shows the geographic impact of Yanming Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanming Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanming Xing more than expected).

Fields of papers citing papers by Yanming Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanming Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanming Xing. The network helps show where Yanming Xing may publish in the future.

Co-authorship network of co-authors of Yanming Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Yanming Xing. A scholar is included among the top collaborators of Yanming Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanming Xing. Yanming Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 8
2 36
3 29
4 6
5 2
6 41
7 60
8 89
9 16

About Yanming Xing

Yanming Xing is a scholar working on Physiology, Gastroenterology and Molecular Biology, having authored 9 papers that have together received 287 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers), Alzheimer's disease research and treatments (7 papers) and Prion Diseases and Protein Misfolding (6 papers). The work is most often cited by research in Physiology (135 citations), Neurology (32 citations) and Nutrition and Dietetics (57 citations). Yanming Xing has collaborated with scholars based in Japan and United States. Frequent co-authors include Keiichi Higuchi, Masayuki Mori, Masanori Hosokawa, Zhanjun Guo, Takatoshi Matsushita, Akihiro Nakamura, Kumiko Kogishi, Takuya Chiba, Xiaoying Fu and Tatsumi Korenaga. Their work appears in journals such as Journal of Biological Chemistry, FEBS Letters and American Journal Of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026